It’s two years since Novartis got its Cosentyx IL-17 drug approved for the spinal disease ankylosing spondylitis, and the Swiss pharma company has new data that it hopes will allow it to compete ...

Cosentyx (secukinumab ... always consult your doctor or another healthcare professional before taking any medication. The drug information contained herein is subject to change and is not intended ...

Novartis says Cosentyx could be used as an early intervention in psoriasis after new data suggests it is the first drug of its kind to modify the course of the disease. The Swiss big pharma ...

Cosentyx and Taltz only target IL-17A, unlike the dual-mechanism Bimzelx. One rheumatologist said UCB’s drug “should work better than Cosentyx” based on the dual mechanism, but it is too ...

Biologics help reduce inflammation in HS. Biologics for HS include Humira and Cosentyx. Humira is an injectable medication approved by the United States Food and Drug Administration (FDA ...

A comparative study will be conducted to demonstrate the efficacy, safety, and equivalence between Cosentyx and CT-P55. CT-P55 received IND approval from the U.S. Food and Drug Administration (FDA ...